Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Concordia Pharmaceuticals, Inc. v. Method Pharmaceuticals, LLC et al
Case Number:
3:14-cv-00016
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 02, 2017
Concordia Pharma Gets False Ad Trial Award Upped To $2.2M
Concordia Pharmaceuticals Inc. on Thursday saw its $730,000 damages award against Method Pharmaceuticals LLC trebled to $2.2 million when a Virginia federal judge said an enhancement was warranted in the false advertising suit over Method's representation its irritable bowel syndrome medication was a valid generic substitute.
-
April 22, 2016
Jury Awards Concordia Pharma $730K In False Ad Row
A Virginia federal jury determined Thursday that Method Pharmaceuticals LLC was liable to rival Concordia Pharmaceuticals Inc. for falsely advertising its irritable bowel syndrome medication as a generic substitute for a drug sold by Concordia, which the jury awarded approximately $730,000 in damages.